Premium Information is available for this item - Upgrade for $1 a day
6505-01-297-3819
Usp Chlorzoxazone Tablets
6505012973819 012973819 01-11892 NDC00182-1189-05 NDC00093-0542-05
January 2023
5
Marketplace 6505-01-297-3819
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-297-3819 5+ Documents (More...)
Usp Chlorzoxazone Tablets 6505012973819 6505012880524 Tablets 6505012705090 023-4521 6505-01-289
-65/fsc-6505/us 6505-00-023-4521 Usp Chlorzoxazone Tablets 6505000234521 Chlorzoxazone Tablets 6505012973819
Tablets 6505000234521 023-4521 6505-01-289-5618 6505-01-270-5090 6505-01-264-4453 6505-01-315-5359 6505-01-297-3819
Tablets 6505012644453 023-4521 6505-01-289-5618 6505-01-270-5090 6505-01-264-4453 6505-01-315-5359 6505-01-297-3819
Usp Chlorzoxazone Tablets 6505012973819 4521 6505-01-289-5618 6505-01-270-5090 6505-01-264-4453
6505-01-315-5359 6505-01-297-3819 Tablets 6505000234521 6505-01-264-4453 6505-01-315-5359 6505-01-297
Restrictions 6505-01-297-3819
6505-01-297-3819 is a Usp Chlorzoxazone Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-297-3819
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-297-3819
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-297-3819
- Part Number
- Manufacturer
- Status
- 01-11892
- Manufacturer
- 63488 - Goldline Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00182-1189-05
- 63488 - Goldline Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00093-0542-05
- 80608 - Lemmon Co (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-297-3819
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 500.000 Milligrams Chlorzoxazone Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500.000 Tablets
Management Data 6505-01-297-3819
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Apr 1991
- Veterans Administration (VA)
- BT
- Subscribe
- 1
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 500 Tt
- 00000000500TT
- K
NATO Stock Numbers Related to 6505-01-297-3819
Freight Information 6505-01-297-3819
6505-01-297-3819 has freight characteristics.. 6505-01-297-3819 has a variance between NMFC and UFC when transported by rail and the description should be consulted.